ArticleBMJ open2024

Decisions to decline breast screening and/or breast cancer treatment based on the potential harms of overdiagnosis and overtreatment: a qualitative study.

Shavez Jeffers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.